UG Healthcare Corporation Limited Stocks

SGD 0.08Last Updated 27.04.2026

Issuer Rating

2/7
Performance

Modest

Risk

High

Recommendation

Sell

Market Cap

SGD 40.07M

Buy
Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
SGD 0.08
Key Takeaways

Risk factor

Very poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very low or no dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

UG Healthcare Corporation Limited, an investment holding company, manufactures and sells disposable gloves. It operates through three segments: Latex Examination Gloves, Nitrile Examination Gloves, and Other Ancillary Products. The company offers latex examination gloves that comprise single chlorinated and double chlorinated polymer coated gloves, as well as nitrile examination gloves. It also distributes ancillary products, including surgical gloves, vinyl and cleanroom disposable gloves, face masks, and other medical disposables, as well as shoe covers and other related products; and provides business and management consultancy services. The company's products are used in healthcare, food and beverage, industrial, high technology manufacturing, automotive, research and development, and beauty sectors. It serves customers under the Unigloves brand name in Malaysia, Europe, North America, South America, Africa, and rest of Asia. The company was founded in 1989 and is based in Singapore.

Company Valuation

Fairly valued
4/7

Considering past and projected metrics, the stock is neither 'expensive' nor 'cheap' compared to its peers. Specifically, the stock is overvalued on EV/EBITDA.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks